256 related articles for article (PubMed ID: 23299616)
1. Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis.
Gopal R; Rangel-Moreno J; Slight S; Lin Y; Nawar HF; Fallert Junecko BA; Reinhart TA; Kolls J; Randall TD; Connell TD; Khader SA
Mucosal Immunol; 2013 Sep; 6(5):972-84. PubMed ID: 23299616
[TBL] [Abstract][Full Text] [Related]
2. A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice.
Ahmed M; Smith DM; Hamouda T; Rangel-Moreno J; Fattom A; Khader SA
Vaccine; 2017 Sep; 35(37):4983-4989. PubMed ID: 28774560
[TBL] [Abstract][Full Text] [Related]
3. Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge.
Monin L; Griffiths KL; Slight S; Lin Y; Rangel-Moreno J; Khader SA
Mucosal Immunol; 2015 Sep; 8(5):1099-109. PubMed ID: 25627812
[TBL] [Abstract][Full Text] [Related]
4. Rationalized design of a mucosal vaccine protects against
Ahmed M; Jiao H; Domingo-Gonzalez R; Das S; Griffiths KL; Rangel-Moreno J; Nagarajan UM; Khader SA
J Leukoc Biol; 2017 Jun; 101(6):1373-1381. PubMed ID: 28258153
[TBL] [Abstract][Full Text] [Related]
5. Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against
Jong RM; Van Dis E; Berry SB; Nguyenla X; Baltodano A; Pastenkos G; Xu C; Fox D; Yosef N; McWhirter SM; Stanley SA
J Immunol; 2022 Jan; 208(2):407-419. PubMed ID: 34965963
[TBL] [Abstract][Full Text] [Related]
6. Lung Epithelial Signaling Mediates Early Vaccine-Induced CD4
Das S; Marin ND; Esaulova E; Ahmed M; Swain A; Rosa BA; Mitreva M; Rangel-Moreno J; Netea MG; Barreiro LB; Divangahi M; Artyomov MN; Kaushal D; Khader SA
mBio; 2021 Aug; 12(4):e0146821. PubMed ID: 34253059
[TBL] [Abstract][Full Text] [Related]
7. PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.
Ashhurst AS; Parumasivam T; Chan JGY; Lin LCW; Flórido M; West NP; Chan HK; Britton WJ
PLoS One; 2018; 13(3):e0194620. PubMed ID: 29554138
[TBL] [Abstract][Full Text] [Related]
8. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.
Ardain A; Domingo-Gonzalez R; Das S; Kazer SW; Howard NC; Singh A; Ahmed M; Nhamoyebonde S; Rangel-Moreno J; Ogongo P; Lu L; Ramsuran D; de la Luz Garcia-Hernandez M; K Ulland T; Darby M; Park E; Karim F; Melocchi L; Madansein R; Dullabh KJ; Dunlap M; Marin-Agudelo N; Ebihara T; Ndung'u T; Kaushal D; Pym AS; Kolls JK; Steyn A; Zúñiga J; Horsnell W; Yokoyama WM; Shalek AK; Kløverpris HN; Colonna M; Leslie A; Khader SA
Nature; 2019 Jun; 570(7762):528-532. PubMed ID: 31168092
[TBL] [Abstract][Full Text] [Related]
9. Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection.
Gopal R; Monin L; Slight S; Uche U; Blanchard E; Fallert Junecko BA; Ramos-Payan R; Stallings CL; Reinhart TA; Kolls JK; Kaushal D; Nagarajan U; Rangel-Moreno J; Khader SA
PLoS Pathog; 2014 May; 10(5):e1004099. PubMed ID: 24831696
[TBL] [Abstract][Full Text] [Related]
10. Pneumocystis-Driven Inducible Bronchus-Associated Lymphoid Tissue Formation Requires Th2 and Th17 Immunity.
Eddens T; Elsegeiny W; Garcia-Hernadez ML; Castillo P; Trevejo-Nunez G; Serody K; Campfield BT; Khader SA; Chen K; Rangel-Moreno J; Kolls JK
Cell Rep; 2017 Mar; 18(13):3078-3090. PubMed ID: 28355561
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium tuberculosis multi-drug-resistant strain M induces IL-17
Basile JI; Kviatcovsky D; Romero MM; Balboa L; Monteserin J; Ritacco V; Lopez B; Sabio y García C; García A; Vescovo M; Montaner PG; Palmero D; Del Carmen Sasiain M; de la Barrera S
Clin Exp Immunol; 2017 Jan; 187(1):160-173. PubMed ID: 27681197
[TBL] [Abstract][Full Text] [Related]
12. IL-22 is mainly produced by IFNγ-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection.
Behrends J; Renauld JC; Ehlers S; Hölscher C
PLoS One; 2013; 8(2):e57379. PubMed ID: 23460846
[TBL] [Abstract][Full Text] [Related]
13. Enhanced effect of BCG vaccine against pulmonary Mycobacterium tuberculosis infection in mice with lung Th17 response to mycobacterial heparin-binding hemagglutinin adhesin antigen.
Fukui M; Shinjo K; Umemura M; Shigeno S; Harakuni T; Arakawa T; Matsuzaki G
Microbiol Immunol; 2015 Dec; 59(12):735-43. PubMed ID: 26577130
[TBL] [Abstract][Full Text] [Related]
14. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
[TBL] [Abstract][Full Text] [Related]
15. Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection.
Sia JK; Bizzell E; Madan-Lala R; Rengarajan J
PLoS Pathog; 2017 Aug; 13(8):e1006530. PubMed ID: 28767735
[TBL] [Abstract][Full Text] [Related]
16. CXCR5⁺ T helper cells mediate protective immunity against tuberculosis.
Slight SR; Rangel-Moreno J; Gopal R; Lin Y; Fallert Junecko BA; Mehra S; Selman M; Becerril-Villanueva E; Baquera-Heredia J; Pavon L; Kaushal D; Reinhart TA; Randall TD; Khader SA
J Clin Invest; 2013 Feb; 123(2):712-26. PubMed ID: 23281399
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
18. CXCL13-mediated recruitment of intrahepatic CXCR5
Li Y; Tang L; Guo L; Chen C; Gu S; Zhou Y; Ye G; Li X; Wang W; Liao X; Wang Y; Peng X; Liu G; Zhang X; Sun J; Peng J; Hou J
J Hepatol; 2020 Mar; 72(3):420-430. PubMed ID: 31610223
[TBL] [Abstract][Full Text] [Related]
19. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis.
Ballester M; Nembrini C; Dhar N; de Titta A; de Piano C; Pasquier M; Simeoni E; van der Vlies AJ; McKinney JD; Hubbell JA; Swartz MA
Vaccine; 2011 Sep; 29(40):6959-66. PubMed ID: 21787826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
